This article provides a comprehensive analysis of the comparative outcomes between Baroreflex Activation Therapy (BAT) and Guideline-Directed Medical Therapy (GDMT) for resistant hypertension and heart failure.
This comprehensive guide provides drug development researchers and scientists with an in-depth exploration of Basophil Activation Test (BAT) systems.
This article provides a comprehensive analysis of patient selection criteria for Baroreflex Activation Therapy (BAT) in individuals with heart failure classified as NYHA Class III.
This article provides a comprehensive guide to Brown Adipose Tissue (BAT) lead placement, addressing core challenges for researchers and drug development professionals.
This article examines Biventricular Pacing (BVP) and its alternatives in patients with heart failure (HF) ineligible for conventional Cardiac Resynchronization Therapy (CRT).
This article provides a comprehensive analysis of Baroreceptor Activation Therapy (BAT) as an emerging device-based treatment for patients with heart failure with reduced ejection fraction (HFrEF) and concomitant coronary artery...
This comprehensive review details the surgical technique for Baroreceptor Activation Therapy (BAT) device implantation at the carotid sinus, tailored for researchers and drug development professionals.
This comprehensive review synthesizes current research on the influence of Brown Adipose Tissue (BAT) activation on muscle sympathetic nerve activity (MSNA).
This article provides a comprehensive review of Brown Adipose Tissue (BAT) as a novel therapeutic target in cardiovascular disease.
This review synthesizes current clinical evidence on the role of brown adipose tissue (BAT) activation as a therapeutic target for reducing hospitalizations related to cardiometabolic diseases.